STAT13h
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
pharmaphorum10h
The future of multiple myeloma is personalised, but we must work together to deliver it
The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...
Study confirms guideline interventions are critical in reducing opioid dispensing
Researchers in Australia have completed a review of a trial focused on reducing opioid dispensing in emergency room settings ...
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...
What People Get Wrong About the Keto Diet
While it’s not as popular as it once was, the keto diet is still firmly in the mainstream, making the list of the top 15 most ...
GlobalData on MSN8h
4C Medical enrols first patients in pivotal mitral valve trial
US-based 4C Medical has enrolled the first patients in a pivotal trial for its transcatheter mitral valve replacement (TMVR) ...